LeivaOrly Profile Banner
Orly Leiva, MD Profile
Orly Leiva, MD

@LeivaOrly

Followers
4K
Following
29K
Media
387
Statuses
6K

IC fellow @UKYMedicine, #cardioonc, #cardioheme Alum: AHFT @UCCardsFellows 🫀@NYUgrossman IM @BrighamMedRes @BUmedicine @wrightstate. 🇬🇹. ⚽️ Views own

Lexington, KY
Joined October 2019
Don't wanna be here? Send us removal request.
@LeivaOrly
Orly Leiva, MD
6 years
I can't wait to be an attending cardiologist and PI so I can run an Afib trial named TIRED-AF because that's my life right now. #medtwitter #cardiotwitter
10
13
399
@JAMAOnc
JAMA Oncology
18 hours
A validated risk model accurately predicted 10-year risk of heart failure or cardiomyopathy in women treated for early-stage breast cancer, integrating clinical and treatment variables available at diagnosis. https://t.co/oByvJ4MMRO
1
12
21
@RanLeeMD
Ran Lee, MD, FACC
7 days
Excellent LVAD session going over hemodynamics, complications, alarms, and codes from @MarkBelkinMD @emilyzernMD @AndrewHigginsMD @BalimSenmanMD with expert panel from @TaniaAhuja @aniket_rali @JasonKatzMD #critcarecards25 @nyulangone
1
10
56
@LeivaOrly
Orly Leiva, MD
11 days
We’re close to @AHAScience #AHA25. Excited to present our work on the CV implications of PH and hemodynamic phenotypes in patients with #MPNsm. Looking forward to catching up with old friends and network with new ones! #cardioonc #hemodynamics @GabyHobbs @datsunian
0
2
11
@awgaffney
Adam Gaffney
16 days
... claim that that Democrats are shutting down the government to "fund healthcare for illegal immigrants" or however they put it. It's xenophobic nonsense from people who would be happy to watch these patients die in the streets. 5/X
1
1
3
@SocietyOfCCC
Society Of Critical Care Cardiology
21 days
🎙️Set your ⏰ because Episode 3 of SoCCC Pre-Rounds podcast drops at 5:00pm ET TODAY! 🎙️ With critical care cardiologists: @AnnGageMD and @zilgiovineMD, and hosted by @ElliottMillerMD.
1
9
31
@LeivaOrly
Orly Leiva, MD
21 days
Interesting study but my brain struggles to understand the rationale of LV EMBx instead of RV. To me, there’s no point of risking stroke/perforation of a higher pressure chamber (though this study didn’t show any stroke).
@ESC_Journals
European Society of Cardiology Journals
22 days
👉LV EMB is a safe diagnostic tool ➕the extent of collagen volume fraction adds prognostic value beyond LVEF and NT-proBNP, improving clinical decision-making 🗞️ https://t.co/ntZ7MbJBX5 #EJHF @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd
0
0
1
@LeivaOrly
Orly Leiva, MD
22 days
Excited to share that we have 4 abstracts accepted at #ASH25 @ASH_hematology. I might be an intv cards in the making, but heme runs in my blood (literally). Looking forward to my 9th ASH! Thanks to @GabyHobbs for her support since day 1! #cardioonc #cardioheme See yall in Orlando
1
2
42
@md_addison
Daniel Addison, MD
23 days
Clonal Hematopoiesis increases Cardiotoxic #AF risk following Allo-stem cell transplant: https://t.co/vSlHjBXZ6b Thanks @JAHA_AHA for publishing. Nice work by @CooperQuar @AdnanShaabanMD @AlmaHabibMD and many others. #CHIP #cardioonc #cancer #leukemia
1
23
43
@MichaelGalvezMD
Michael Galvez, MD
23 days
Tomorrow is National Latino Physician Day. October 1st to create the awareness that only 6% of doctors are Latino in the United States. Well over 25 live events across the country. We are highlighting the worsening physician shortage in the United States. We are highlighting
0
14
34
@LeivaOrly
Orly Leiva, MD
24 days
Honestly, the data for sotatercept is very exciting. Should it be first line for intermediate or high risk PAH along with conventional double or triple therapy? 🤔
@NEJM
NEJM
24 days
Presented at #ERSCongress: Among adults with pulmonary arterial hypertension who had received the diagnosis less than 1 year earlier, the addition of sotatercept to background therapy resulted in a lower risk of clinical worsening than placebo. Full HYPERION phase 3 trial
2
0
6
@AnnieAndrewsMD
Dr. Annie Andrews
1 month
Did we all take organic chemistry & the MCAT & miss the social part of our early 20’s and work 80 hours a week for 3+ years for the brain worm guy who doesn’t know what a p-value is to destroy our nation’s public health system? No. Time to lean into our expertise and speak up.
419
2K
13K
@LeivaOrly
Orly Leiva, MD
1 month
Diltiazem is a great bridge to VA ECMO.
@SandeepNathanMD
Sandeep Nathan, MD, MSc
1 month
@Allison_Dupont presents a challenging, late-presenting #STEMI #CardiogenicShock case at #scaishock2025. Ischemic shock-> valvular shock-> emergent MVR w/entire range of MCS used along the way. But seriously though: Can we just take the Dirty Diltiazem Martini off the menu? 🤦‍♂️
4
0
31
@DrRaulCordoba
Raul Cordoba, MD, PhD
1 month
For patients undergoing #HSCT, the CARE-BMT score has been recently proposed #CardioOnc #hematology #cardiology #bmtsm
0
2
4
@SocietyOfCCC
Society Of Critical Care Cardiology
2 months
🎙️EPISODE 2 of the SoCCC Pre-Rounds podcast just launched and it's AWESOME!! Listen now: https://t.co/goBtVH9vU4 @JasonKatzMD @CCCEnthusiasts @AnnGageMD @jameshorowitzmd @ElliottMillerMD @BalimSenmanMD
1
14
57
@drjohnm
John Mandrola, MD
2 months
The AQUATIC trial may be the most definitive trial of #ESCCOngress The common combo of ASA and OAC for pts with CAD/stent and AF is clearly been harming people. Lots. MACE worse, Death worse, Bleeding way worse. STOP THE ASA when on OAC https://t.co/OSx0UKWPXe
11
129
403
@SocietyOfCCC
Society Of Critical Care Cardiology
2 months
🎙️COMING FRIDAY (9/5)🎙️ Episode 2 of SoCCC Pre-Rounds drops! The Basics of ECMO with Jason Katz, MD, MHS, FACC, FAHA (@JasonKatzMD), President of @SocietyOfCCC, and Critical Care Cardiologist, Simon Parlow, MD, FRCPC (@sdparlow). Listen to Episode 1: https://t.co/E6PeakHfWO
0
7
34
@LeivaOrly
Orly Leiva, MD
2 months
Maybe putting “Goal K > 4.5” in our consult notes has some merit, at least in this patient population 🤔
@NEJM
NEJM
2 months
Presented at #ESCCongress: In patients with cardiovascular disease and an implantable cardioverter–defibrillator, increasing potassium levels to the high-normal range reduced the risk of arrhythmia events, hospitalizations, and death. Full POTCAST trial results:
2
0
16
@LeivaOrly
Orly Leiva, MD
2 months
This was a great editorial to our latest paper @CircAHA. We are just beginning to scratch the surface of pulmonary vascular oncology, a subset of cardio-oncology, and #mpnsm highlight the importance of understanding this connection Cc @GabyHobbs https://t.co/TjgIVp2F31
0
3
17
@gregorykatz
Greg Katz
2 months
The noninvasive people may ignore data like this But when we are deciding on practical and important questions like duration of DAPT, intravascular imaging really matters Crazy to think about how many underexpanded stents there are out there not placed under imaging guidance!
@piccoloraf
Raffaele Piccolo
2 months
Impact of intracoronary imaging on >70,000 lesions treated with PCI in BMC2: +0.19 mm stent diameter, +0.45 mm maximum balloon diameter, and +3.51 mm stent length. @SVRaoMD @mmamas1973 @mirvatalasnag @Hragy @jedicath @ziadalinyc @CircAHA Full link 🔗 👇 https://t.co/TFYpyjng2p
0
4
7
@JACCJournals
JACC Journals
2 months
🚨 New #JACCCardioOnc Special Issue! Dive into the bidirectional links between cancer & #CVD and their impact on research & patient care in this special focus issue: https://t.co/uIEHxhrvcW #CardioOnc @DrBonnieKy
1
7
23